ArgusEye - Prototype validation and business plan implementation

Reference number 2018-03144
Coordinator ArgusEye AB
Funding from Vinnova SEK 900 000
Project duration January 2019 - June 2020
Status Ongoing
Venture Innovative Startups
Call Innovative Startups Step 2 autumn 2018

Purpose and goal

ArgusEye AB develops innovative sensor systems for online monitoring of biological systems and processes, focusing on the production of biological pharmaceuticals. The objective of the project is primarily to validate the company´s sensor technology in a large-scale production of therapeutic antibodies. The project also includes extended discussions with potential customers and investors.

Expected results and effects

The technical validation will provide ArgusEye with extended knowledge and important insights into the technological challenges that arise in the large-scale production of biological pharmaceuticals. The result of the validation will be of significant importance for future product development as well as for extended customer discussions. The project is expected to result in new IP and thus contribute to the company´s market introduction of the sensor technology.

Planned approach and implementation

An updated prototype, more optimized for large scale production regarding size, choice of material etc. will be developed. Once the prototype is completed, it will be validated at the newly established TESTA center in Uppsala where necessary equipment and resources are available. During the later phase of the project, extended discussions with potential customers and investors will also be initiated.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.